Calendar Belite Bio, Inc

Equities

BLTE

US07782B1044

Market Closed - Nasdaq 04:00:00 2024-02-27 pm EST 5-day change 1st Jan Change
46.15 USD -1.35% Intraday chart for Belite Bio, Inc -2.31% +0.87%

Chart calendar Belite Bio, Inc

55cf5b161a5689.LQq5hGifuYmpnd4oe8MunZJQmBTf1A62-GVCfJartys.fXPd1C7r8uHH8rZ7NPtf8fMH6yS4g1ziji80D8zvjxtFZfbeCeXruZvajw~c34ce69b837e135f0b375061dd8e056a

Upcoming events on Belite Bio, Inc

2024-03-28 Q4 2023 Earnings Release (Projected)
2024-05-07 Q1 2024 Earnings Release (Projected)
2024-08-06 Q2 2024 Earnings Release (Projected)
2025-03-27 Q4 2024 Earnings Release (Projected)

Past events on Belite Bio, Inc

2023-12-06 Benchmark Company Discovery Conference
2023-11-27 03:00 pm BTIG Ophthalmology Day
2023-11-14 04:30 pm Q3 2023 Earnings Call
2023-11-13 08:15 pm Q3 2023 Earnings Release
2023-11-08 11:00 am Deutsche Bank Depositary Receipts Virtual Investor Conference
2023-11-05 06:57 pm American Academy Of Ophthalmology Meeting
2023-09-25 Cantor Global Healthcare Conference
2023-09-13 H.C. Wainwright Global Investment Conference
2023-08-09 04:30 pm Q2 2023 Earnings Call
2023-08-08 10:17 pm Q2 2023 Earnings Release
2023-05-11 08:00 am Q1 2023 Earnings Call
2023-05-09 Q1 2023 Earnings Release
2023-05-03 01:00 pm Investor Meeting - Key Opinion Leader
2023-04-25 09:45 am Association for Research in Vision and Ophthalmology Meeting
2023-04-03 04:30 pm Q4 2022 Earnings Call
2023-03-31 07:03 pm Q4 2022 Earnings Release
2022-10-27 11:00 am Investor Meeting - key Opinion Leader
2022-10-01 10:20 am American Academy of Ophthalmology Eyecelerator Conference - Abstract Number 30071744
2022-09-12 08:00 am H.C. Wainwright Global Investment Conference
2022-08-17 07:00 am H.C. Wainwright & Co. Ophthalmology Virtual Conference

Annual results

Fiscal PeriodDecember 2021 2022 2023
Net sales
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-

0,00

EBITDA
Released
Forecast
Spread
0,00


0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
0,00


-12,8
-13,5
5.27%

-32,1

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-12,6
-13,4
5.88%

-32,1

Net income
Million USD
Released
Forecast
Spread
-9,67


-12,6
-13,4
5.88%

-32,8

EPS
USD
Released
Forecast
Spread
-1,01


-0,63
-0,66
3.82%

-1,29

Announcement Date15/03/2231/03/23-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1
Net sales
Million USD
Released
Forecast
Spread

0,00


0,00


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-1,78
-4,03
55.78%

-4,73


-4,35


-5,63


-5,02

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-1,73
-4,03
57.02%

-4,73


-4,35


-5,63


-5,02

Net income
Million USD
Released
Forecast
Spread
-1,73
-4,03
57.02%

-4,73


-4,35


-5,63


-5,02

EPS
USD
Released
Forecast
Spread
-0,12
-0,29
57.89%

-0,24


-0,18


-0,23


-0,20

Announcement Date11/08/22----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW